$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in REGENERON PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in REGENERON PHARMACEUTICALS, INC. for free.

CIK Number: 0000872589
IRS Number: 133444607
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: REGN
Company Address: 777 OLD SAW MILL RIVER ROAD TARRYTOWN 10591
Former name: REGENERON PHARMACEUTICALS INC, date of change: 1993-03-28

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Market Capitalization: $37.03B
Prev close: $357.69
Average Daily Volume: 998,052
Days Low: $351.03
Year Low: $325.35
Year High: $452.96

REGENERON PHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
McCourt MarionEVP Commercial18,0386,452,012shares bought: 18,575 / shares sold: -3,000 STRONG BUYMay 10 20213 months ago

View all REGENERON PHARMACEUTICALS, INC. insiders.

REGENERON PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2021REGNREGENERON PHARMACE ...McCourt MarionEVP CommercialOption ExerciseM342.931,000342,93017,000
May 10 2021REGNREGENERON PHARMACE ...McCourt MarionEVP CommercialSellS495.631,000495,63017,03818 K to 17 K (-5.54 %)
May 10 2021REGNREGENERON PHARMACE ...McCourt MarionEVP CommercialBuyM342.931,000342,93018,03817 K to 18 K (+5.87 %)
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorOption ExerciseM52.03248,07912,907,5500
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorOption ExerciseM52.031,92199,9500
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorGiftG0.004140142,796143.2 K to 142.8 K (-0.29 %)
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorPayment of ExerciseF458.48137,99863,269,323349,090487.1 K to 349.1 K (-28.33 %)
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorBuyM52.03248,07912,907,550487,088239 K to 487.1 K (+103.79 %)
Feb 24 2021REGNREGENERON PHARMACE ...VAGELOS P ROYDirectorBuyM52.031,92199,950239,009237.1 K to 239 K (+0.81 %)
Feb 18 2021REGNREGENERON PHARMACE ...REGENERON PHARMACEUTICALS, INC ...10% OwnerOption ExerciseC0.0014,000,00000
Feb 18 2021REGNREGENERON PHARMACE ...REGENERON PHARMACEUTICALS, INC ...10% OwnerOption ExerciseC0.0012,500,00000
Feb 18 2021REGNREGENERON PHARMACE ...REGENERON PHARMACEUTICALS, INC ...10% OwnerBuyC0.002,097,31402,097,3140 to 2.1 M
Feb 02 2021REGNREGENERON PHARMACE ...RYAN ARTHUR FDirectorSellS512.8221,02623,69123.7 K to 23.7 K (-0.01 %)
Feb 02 2021REGNREGENERON PHARMACE ...RYAN ARTHUR FDirectorSellS509.2842,03723,69323.7 K to 23.7 K (-0.02 %)
Feb 02 2021REGNREGENERON PHARMACE ...RYAN ARTHUR FDirectorSellS508.52168,13623,69723.7 K to 23.7 K (-0.07 %)

View all REGENERON PHARMACEUTICALS, INC. insider transactions.